FDA Approves New Combination Therapy for Breast Cancer

Oncologists and women suffering from breast cancer may have yet another tool in their fight against the disease. Genentech, Inc. has announced this week that the FDA will be granting an accelerated approval for Avastin (bevacizumab) in combination with paclitaxel chemotherapy for HER2-negative women who have not yet received chemotherapy. Read more

Drug Maker & Ophthalmologists See Eye to Eye

Med Headlines - A compromise announced Thursday between eye doctors and the biotechnology company Genentech promises to keep supplies steady of a drug used to treat macular degeneration. The drug in question is Avastin, which has US Food & Drug Administration (FDA) approval for use as a cancer treatment. It is not approved for use in treating macular degeneration, one of the main causes of blindness in older people.

Read more